Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03706443 · ClinicalTrials.gov registry record · NA
Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03706443 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 24 participants.
The verdict
NCT03706443, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Cross-over comparison of lipid layer thickness and dry eye symptoms with two artificial tear formulations.
Interventions
- OTHER Systane Complete
- OTHER Systane Ultra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2019-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03706443
The ClinicalTrials.gov registry entry for NCT03706443 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Systane Complete is the first listed.
NCT03706443 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03706443 about?
NCT03706443 is a clinical study titled "Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops". Cross-over comparison of lipid layer thickness and dry eye symptoms with two artificial tear formulations.
What is the current status of trial NCT03706443?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-12-05. Estimated completion is 2019-02-28.
What interventions are being tested in trial NCT03706443?
The interventions under investigation include: Systane Complete (OTHER), Systane Ultra (OTHER).
Who is sponsoring clinical trial NCT03706443?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.